BioCentury
ARTICLE | Company News

ChemTrak other research news

July 5, 1994 7:00 AM UTC

The Sunnyvale, Calif., company received a $500,000 Phase II SBIR grant from the National Heart, Lung, and Blood Institute to further develop CMTR's high-density lipoprotein diagnostics. CMTR is develo...